Leonteq Securities AG’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
Other funds holding ALT
DTC
TCM
RCM
Leonteq Securities AG's ALT Position: Q2 2026 in Review
Leonteq Securities AG reduced its Altimmune (ALT) stake by 1.5% in Q2 2026, selling an estimated $2.99K and leaving 64,000 shares worth $195K. The position accounts for 0.01% of the portfolio, ranked #575.
Leonteq Securities AG first reported a position in ALT in Q4 2023 and has held it in 5 quarters since. The position peaked at $200K in Q1 2026. 208 funds tracked by Wall St. Rank hold ALT as of Q2 2026.
- Leonteq Securities AG held 64,000 shares of Altimmune worth $195K as of Q2 2026.
- Leonteq Securities AG sold 1,000 Altimmune shares in Q2 2026, an estimated $2.99K.
- Altimmune made up 0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #575 holding.
- Leonteq Securities AG first reported a position in Altimmune in Q4 2023 and has held it in 5 quarters since.
- Leonteq Securities AG's Altimmune position peaked at $200K in Q1 2026.
- 208 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.
Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.